Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis

被引:10
|
作者
Kolb, TM
Duan, L
Davis, MA
机构
[1] Lilly Res Labs, Toxicol & Drug Disposit, Greenfield, IN 46140 USA
[2] Univ Maryland, Sch Med, Toxicol Program, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
tumorigenesis; Tsc2; apoptosis; okadaic acid;
D O I
10.1093/toxsci/kfi310
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Although the precise role for the tuberous sclerosis complex-2 tumor suppressor gene (Tsc2) in tumor suppression is not clear, many studies have implicated Tsc2 in the regulation of cell differentiation, cell cycle control, GTPase activity, transcription, polycystin-1 localization, and translation initiation. We propose that Tsc2 also increases susceptibility to apoptosis, and that this functional role may contribute to the tumor suppressor activity of Tsc2. We previously characterized the apoptotic response of a Tsc2-null renal tumor cell line (ERC-18) to the tumor promoter okadaic acid (OKA). In the present study, we expressed Tsc2 in ERC-18 cells and compared the effect of Tsc2 expression on apoptotic induction. Tsc2 expression increased the susceptibility of ERC-18 cells to apoptosis induced by OKA and the phosphatidylinositol-3' kinase inhibitor, LY294002. In addition, Tsc2 expression abrogated OKA-induced cell detachment of ERC-18 cells. These results indicate that the OKA-induced, caspase-independent detachment previously observed in ERC-18 cells is Tsc2-dependent, and may support an additional role for the Tsc2 in regulating cell adhesion.
引用
收藏
页码:331 / 339
页数:9
相关论文
共 50 条
  • [31] Tsc2 Mutation Induces Renal Tubular Cell Nonautonomous Disease
    Kumar, Prashant
    Al-Zadjali, Fahad
    Yao, Ying
    Bissler, John J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 399 - 399
  • [32] Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex
    Yi Li
    Matthew J. Barkovich
    Celeste M. Karch
    Ryan M. Nillo
    Chun-Chieh Fan
    Iris J. Broce
    Chin Hong Tan
    Daniel Cuneo
    Christopher P. Hess
    William P. Dillon
    Orit A. Glenn
    Christine M. Glastonbury
    Nicholas Olney
    Jennifer S. Yokoyama
    Luke W. Bonham
    Bruce Miller
    Aimee Kao
    Nicholas Schmansky
    Bruce Fischl
    Ole A. Andreassen
    Terry Jernigan
    Anders Dale
    A. James Barkovich
    Rahul S. Desikan
    Leo P. Sugrue
    Scientific Reports, 8
  • [33] Tuberin (TSC2) and hamartin (TSC1) expression in human fetal and child brains
    Park, SH
    Emelin, J
    Vinters, HV
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 515 - 515
  • [34] Tsc2 mutation induces renal tubular cell nonautonomous disease
    Kumar, Prashant
    Zadjali, Fahad
    Yao, Ying
    Johnson, Daniel
    Siroky, Brian
    Astrinidis, Aristotelis
    Vogel, Peter
    Gross, Kenneth W.
    Bissler, John J.
    GENES & DISEASES, 2022, 9 (01) : 187 - 200
  • [35] Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex
    Li, Yi
    Barkovich, Matthew J.
    Karch, Celeste M.
    Nillo, Ryan M.
    Fan, Chun-Chieh
    Broce, Iris J.
    Tan, Chin Hong
    Cuneo, Daniel
    Hess, Christopher P.
    Dillon, William P.
    Glenn, Orit A.
    Glastonbury, Christine M.
    Olney, Nicholas
    Yokoyama, Jennifer S.
    Bonham, Luke W.
    Miller, Bruce
    Kao, Aimee
    Schmansky, Nicholas
    Fischl, Bruce
    Andreassen, Ole A.
    Jernigan, Terry
    Dale, Anders
    Barkovich, A. James
    Desikan, Rahul S.
    Sugrue, Leo P.
    SCIENTIFIC REPORTS, 2018, 8
  • [36] Mutations in TSC1 and TSC2 Are Associated with High Tumor Mutational Burden and Therapeutic Options
    Gay, Laurie M.
    Elvin, Julia A.
    Suh, James
    Vergilio, Jo-Anne
    Ramkissoon, Shakti H.
    Schrock, Alexa
    Ali, Siraj M.
    Fabrizio, David
    Frampton, Garrett
    Miller, Vincent
    Stephens, Philip
    Ross, Jeffrey
    LABORATORY INVESTIGATION, 2017, 97 : 457A - 457A
  • [37] Loss of heterozygosity of TSC2 and TSC1 gene in perivascular epitheliold cell tumor (PEComa)
    Pan, CC
    Chung, MY
    LABORATORY INVESTIGATION, 2006, 86 : 153A - 154A
  • [38] TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling
    Lin, Chun-Pu
    Traets, Joleen J. H.
    Vredevoogd, David W.
    Visser, Nils L.
    Peeper, Daniel S.
    EMBO JOURNAL, 2023, 42 (05):
  • [39] Mutations in TSC1 and TSC2 Are Associated with High Tumor Mutational Burden and Therapeutic Options
    Gay, Laurie M.
    Elvin, Julia A.
    Suh, James
    Vergilio, Jo-Anne
    Ramkissoon, Shakti H.
    Schrock, Alexa
    Ali, Siraj M.
    Fabrizio, David
    Frampton, Garrett
    Millet, Vincent
    Stephens, Philip
    Ross, Jeffrey
    MODERN PATHOLOGY, 2017, 30 : 457A - 457A
  • [40] Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis - Role for tumor suppressor TSC2
    Goncharova, EA
    Goncharov, DA
    Spaits, M
    Noonan, DJ
    Talovskaya, E
    Eszterhas, A
    Krymskaya, VP
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (05) : 561 - 572